A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals

Gut

Volumn 65, Issue 9, 2016, Pages 1505-1513

  Harinck, F ^a   Konings, I C A W ^a   Kluijt, I ^b   Poley, J W ^a   Van Hooft, J E ^c   Van Dullemen, H M ^d   Nio, C Y ^c   Krak, N C ^a   Hermans, J J ^e   Aalfs, C M ^c   Wagner, A ^a   Sijmons, R H ^d   Biermann, K ^a   Van Eijck, C H ^a   Gouma, D J ^c   Dijkgraaf, M G W ^c   Fockens, P ^c   Bruno, M J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

endoscopic ultrasonography; magnetic resonance imaging; Pancreatic cancer; screening; surveillance

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; CANCER STAGING; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENDOSCOPIC ULTRASONOGRAPHY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS CYST; PRIORITY JOURNAL; PROSPECTIVE STUDY; TUMOR VOLUME; ASYMPTOMATIC DISEASE; CARCINOMA, PANCREATIC DUCTAL; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; COMPARATIVE STUDY; EARLY CANCER DIAGNOSIS; MIDDLE AGED; NETHERLANDS; PANCREAS; PANCREATIC CYST; PANCREATIC NEOPLASMS; PATHOLOGY; PROCEDURES; STATISTICS AND NUMERICAL DATA;

ADULT; ASYMPTOMATIC DISEASES; CARCINOMA, PANCREATIC DUCTAL; COHORT STUDIES; COMPARATIVE EFFECTIVENESS RESEARCH; EARLY DETECTION OF CANCER; ENDOSONOGRAPHY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NETHERLANDS; PANCREAS; PANCREATIC CYST; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES;

EID: 84985905020     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2014-308008     Document Type: Article

References (26)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Canto MI, Harinck F, Hruban RH, et al. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut 2013;62:339-47.
3. Korsse SE, Harinck F, van Lier MG, et al. Pancreatic cancer risk in Peutz-Jeghers syndrome patients: a large cohort study and implications for surveillance. J Med Genet 2013;50:59-64.
4. Al-Sukhni W, Borgida A, Rothenmund H, et al. Screening for Pancreatic Cancer in a High-Risk Cohort: An Eight-Year Experience. J Gastrointest Surg 2011;16:771-83.
5. Brentnall TA, Bronner MP, Byrd DR, et al. Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med 1999;131:247-55.
6. Canto MI, Goggins M, Hruban RH, et al. Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol 2006;4:766-81; quiz 665.
7. Canto MI, Goggins M, Yeo CJ, et al. Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol 2004;2:606-21.
8. Canto MI, Hruban RH, Fishman EK, et al. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology 2012;142:796-804; quiz e14-5.
9. Langer P, Kann PH, Fendrich V, et al. Five years of prospective screening of highrisk individuals from families with familial pancreatic cancer. Gut 2009;58:1410-8.
10. Ludwig E, Olson SH, Bayuga S, et al. Feasibility and yield of screening in relatives from familial pancreatic cancer families. Am J Gastroenterol 2011;106:946-54.
11. Poley JW, Kluijt I, Gouma DJ, et al. The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer. Am J Gastroenterol 2009;104:2175-81. .
12. Verna EC, Hwang C, Stevens PD, et al. Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics. Clin Cancer Res 2010;16:5028-37.
13. Vasen HF, Wasser M, van Mil A, et al. Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation. Gastroenterology 2011;140:850-6.
14. de Snoo FA, Bishop DT, Bergman W, et al. Increased risk of cancer other than melanoma in CDKN2A founder mutation ( p16-Leiden)-positive melanoma families. Clin Cancer Res 2008;14:7151-7.
15. van Asperen CJ, Brohet RM, Meijers-Heijboer EJ, et al. Cancer risks in BRCA2 families: estimates for sites other than breast and ovary. J Med Genet 2005;42:711-19.
16. Thompson D, Easton DF. Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 2002;94:1358-65.
17. Ruijs MW, Verhoef S, Rookus MA, et al. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes. J Med Genet 2010;47:421-8.
18. Iqbal J, Ragone A, Lubinski J, et al. The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers. Br J Cancer 2012;107:2005-9.
19. Brand RE, Lerch MM, Rubinstein WS, et al. Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut 2007;56:1460-9.
20. Tanaka M, Fernandez-del Castillo C, Adsay V, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 2012;12:183-97.
21. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74.
22. Kimmey MB, Bronner MP, Byrd DR, et al. Screening and surveillance for hereditary pancreatic cancer. Gastrointest Endosc 2002;56(4 Suppl):S82-6.
23. Schneider R, Slater EP, Sina M, et al. German national case collection for familial pancreatic cancer (FaPaCa): ten years experience. Fam Cancer 2011;10:323-30.
24. Shin EJ, Topazian M, Syngal S, et al. Radial versus linear and second look endoscopic ultrasound (EUS) improved detection of pancreatic lesions: a randomized tandem study. Gastrointest Endosc 2012;75:131-1.
25. Harinck F, Bruno MJ. Endosonography in the management of biliopancreatic disorders. Best Pract Res Clin Gastroenterol 2009;23:703-10.
26. Kamata K, Kitano M, Kudo M, et al. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms. Endoscopy 2014;46:22-9.